Icoria, which was known as Paradigm Genetics until a name change this summer, is facing delisting from Nasdaq and is looking for a new chief financial officer.
Icoria (Nasdaq: ICOR)’s stock is likely to be delisted since its stock has traded at less than $1 for several months, the company said Monday.
In its quarterly earnings report, Icoria also disclosed that Phil Alfano, its chief financial officer, would soon leave the firm.
For details of Icoria’s earnings, see: biz.yahoo.com/prnews/041108/clm030a_1.html
